Given the critical role of the NF-κB pathway in HCC resistance to TRAIL, identifying more lncRNA CASC2/miRNA axes modulating the NF-κB pathway in HCC cells might provide novel targets for restoring TRAIL sensitivity. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.